Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0419 per EA under NDC 69097084705. Its NADAC has been published 524 times since Aug 10, 2016.
FDA first approved this application on Sep 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097084705
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA078604FDA Approved
9/11/2012
TE Code
AB
On Market Since
6/16/2016
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 524 times since Aug 10, 2016, and over the history we have for it it has declined 64.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0419 per EA |
|---|---|
| All-time high | $0.1336 (Oct 12, 2016) |
| All-time low | $0.0328 (Nov 20, 2024) |
| 52-week high | $0.0472 |
| 52-week low | $0.0412 |
| Median price | $0.0570 |
| Average price | $0.0610 |
| Largest weekly change | +34.3% (Dec 21, 2016) |
| Weeks tracked | 524 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Cipla USA Inc., is $0.0419 per EA (NDC 69097084705), effective Aug 19, 2026.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 64.4%. It has been tracked across 524 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since Aug 10, 2016, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.1336 (Oct 12, 2016), with a median of $0.0570 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 5 MG TABLET, is $0.0419 per EA — about 0% below ESCITALOPRAM 5 MG TABLET.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 69097084705) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.